Supportive Care in Cancer

, Volume 16, Issue 2, pp 171–179 | Cite as

The influence of xerostomia after radiotherapy on quality of life

Results of a questionnaire in head and neck cancer
  • Piet Dirix
  • Sandra Nuyts
  • Vincent Vander Poorten
  • Pierre Delaere
  • Walter Van den Bogaert
Original Article



Xerostomia is a common complication of radiotherapy for head and neck cancer because irreparable damage is caused to the salivary glands if they are included in the radiation fields. The aim of the study was to evaluate the degree of xerostomia in survivors of head and neck cancer and to determine its impact on quality of life.

Methods and materials

A xerostomia questionnaire consisting of three parts (xerostomia score, quality of life survey, and visual analogue scale) was completed by 75 head and neck cancer patients, more than 6 months after radiotherapy and without evidence of disease.


The majority of patients (93%) suffered from a dry mouth, and 65% had moderate to severe xerostomia (grade 2 to 3). Both dysphagia (65%) and taste loss (63%) were common, although oral pain was less frequent (33%). The emotional impact of xerostomia was significant, causing worry (64%), tension (61%), or feelings of depression (44%). Furthermore, patients reported problems with talking to (60%) or eating with (54%) other people and to feel restricted in amount and type of food (65%). Quality of life was influenced by T classification, clinical stage, a higher radiation dose or the use of concomitant chemotherapy, but was independent of the interval since the end of radiotherapy.


Xerostomia after radiotherapy for head and neck cancer is extremely common and significantly affects quality of life. No recuperation is seen over time, and the use of concomitant chemotherapy significantly increases the oral complications of radiation. These results warrant the continuing efforts put into the development of salivary gland-sparing radiotherapy techniques and effective treatments of radiation-induced xerostomia.


Head and neck Radiotherapy Xerostomia Quality of life Salivary glands 



This work was supported by grants from the Vlaamse Liga tegen Kanker (VLK) and the Klinisch Onderzoeksfonds (KOF).

Conflict of interest

All authors have read and approved the manuscript; we have no conflicts of interest to declare or financial support from industry sources to disclose.


  1. 1.
    Bjordal K, Kaasa S, Mastekaasa A (1994) Quality of life in patients treated for head and neck cancer. Int J Radiat Oncol Biol Phys 28:847–856PubMedGoogle Scholar
  2. 2.
    Bjordal K, Freng A, Thorvik J, Kaasa S (1995) Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study. Oral Oncol 31:235–241Google Scholar
  3. 3.
    Braam PM, Roesink JM, Moerland MA et al (2005) Long-term parotid gland function after radiotherapy. Int J Radiat Oncol Biol Phys 62:659–664PubMedCrossRefGoogle Scholar
  4. 4.
    Braam PM, Roesink JM, Raaijmakers C, Busschers W, Terhaard C (2007) Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy. Radiat Oncol 2:3PubMedCrossRefGoogle Scholar
  5. 5.
    Bussels B, Maes A, Flamen P et al (2004) Dose–response relationships within the parotid gland after radiotherapy for head and neck cancer. Radiother Oncol 73:297–306PubMedCrossRefGoogle Scholar
  6. 6.
    Dirix P, Nuyts S, Van den Bogaert W (2006) Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 107(11):2525–2534PubMedCrossRefGoogle Scholar
  7. 7.
    Dirix P, Nuyts S, Vander Poorten V, Van den Bogaert W (2007) Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia. Support Care Cancer (in press; E-pub ahead of print)Google Scholar
  8. 8.
    Duncan GG, Epstein JB, Tu D, El Sayed S, Bezjak A, Ottaway J, Pater J (2005) Quality of life, mucositis and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucostis. Head Neck 27:421–428PubMedCrossRefGoogle Scholar
  9. 9.
    Eisbruch A, Rhodus N, Rosenthal D et al (2003) How should we measure and report radiotherapy-induced xerostomia? Semin Radiat Oncol 13:226–234PubMedCrossRefGoogle Scholar
  10. 10.
    Eisbruch A, Terrell JE (2003) Letters to the editor. Head Neck 25:1082–1083PubMedCrossRefGoogle Scholar
  11. 11.
    Epstein JB, Emerton S, Kolbinson DA et al (1999) Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 21:1–11PubMedCrossRefGoogle Scholar
  12. 12.
    Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P (2001) Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 23:389–398PubMedCrossRefGoogle Scholar
  13. 13.
    Guchelaar H, Vermes A, Meerwaldt JH (1997) Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer 5:281–288PubMedCrossRefGoogle Scholar
  14. 14.
    Harrison L, Zelefski M, Pfitzer D et al (1997) Detailed quality of life assessment in patients treated with primary radiotherapy for cancer of the base of tongue. Head Neck 19:169–175PubMedCrossRefGoogle Scholar
  15. 15.
    Hassan SJ, Weymuller EA (1993) Assessment of quality of life in head and neck cancer patients. Head Neck 15:485–496PubMedCrossRefGoogle Scholar
  16. 16.
    Henk JM (1997) Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity. Clin Oncol 9:308–312CrossRefGoogle Scholar
  17. 17.
    Hoopman R, Muller MJ, Terwee CB, Aaronson NK (2006) Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the Netherlands. Eur J Cancer 42(12):1839–1847PubMedCrossRefGoogle Scholar
  18. 18.
    Jemal A, Siegel R, Ward E et al (2006) Cancer statistics. CA Cancer J Clin 56:106–130PubMedCrossRefGoogle Scholar
  19. 19.
    Long SA, D’Antonio LL, Robinson EB, Zimmerman G, Petti G, Chonkich G (1996) Factors related to quality of life and functional status in 50 patients with head and neck cancer. Laryngoscope 106:1084–1088PubMedCrossRefGoogle Scholar
  20. 20.
    Maes A, Weltens C, Flamen P et al (2002) Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol 63:203–211PubMedCrossRefGoogle Scholar
  21. 21.
    Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C, Eisbruch A (2006) Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys 66(2):445–453PubMedGoogle Scholar
  22. 22.
    Meyer TK, Kuhn JC, Campbell BH et al (2004) Speech intelligibility and quality of life in head and neck survivors. Laryngoscope 114:1977–1981PubMedCrossRefGoogle Scholar
  23. 23.
    Nieuw Amerongen AV, Veerman ECI (2003) Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 11:226–231PubMedGoogle Scholar
  24. 24.
    Roesink J, Schipper M, Busschers W, Raaijmakers C, Terhaard C (2005) A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials. Int J Radiat Oncol Biol Phys 63:1006–1009PubMedCrossRefGoogle Scholar
  25. 25.
    Thoeny H, De Keyzer F, Claus F, Sunaert S, Hermans R (2005) Gustatory stimulation changes the apparent diffusion coefficient of salivary glands: initial experience. Radiology 235:629–634PubMedCrossRefGoogle Scholar
  26. 26.
    Van Acker F, Flamen P, Lambin P et al (2001) The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy. Nucl Med Common 22:225–231CrossRefGoogle Scholar
  27. 27.
    Weymuller EA, Yueh B, Deleyiannis F et al (2000) Quality of life in head and neck cancer. Laryngoscope 110(Suppl 94):4–7PubMedCrossRefGoogle Scholar
  28. 28.
    Weymuller EA, Yueh B, Deleyiannis F et al (2000) Quality of life in patients with head and neck cancer. Lessons learned from 549 prospectively evaluated patients. Arch Otolaryngol Head Neck Surg 126:329–335PubMedGoogle Scholar
  29. 29.
    Wijers O, Levendag P, Braaksma M, Boonzaaijer M, Visch L, Schmitz P (2002) Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head Neck 24:737–747PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Piet Dirix
    • 1
  • Sandra Nuyts
    • 1
  • Vincent Vander Poorten
    • 2
  • Pierre Delaere
    • 2
  • Walter Van den Bogaert
    • 1
  1. 1.Department of Radiation Oncology, Leuvens Kanker Instituut (LKI)University Hospital GasthuisbergLeuvenBelgium
  2. 2.Department of Otorhinolaryngology, Head and Neck Surgery, Leuvens Kanker Instituut (LKI)University Hospital GasthuisbergLeuvenBelgium

Personalised recommendations